Back to results
US 2024/0197838 A1Published application
mRNA NANOCAPSULE
AssigneeVL Biotech Inc.
InventorChiao-long HSIAO
Life of this patent
Estimating the term…
Abstract
The present invention provides an mRNA nanocapsule and use thereof, comprising a virus-like particle (VLP) formed by self-assembly of a plurality of capsid proteins (CPs), an mRNA encoding Cas13 protein, and a guide RNA. The mRNA includes a capsid protein binding tag to be encapsidated in the VLP so that the mRNA can stably enter cells and the Cas13 protein can be translated.
Claims7
An mRNA nanocapsule, comprising:
- a plurality of capsid proteins, self-assembling into a virus-like particle, wherein each of the capsid proteins comprises an RNA-binding motif;
- one or more first RNA molecules, comprising an mRNA encoding a Cas13 protein and a capsid protein binding tag, wherein the capsid protein binding tag recognizes and binds to the RNA-binding motif of one of the capsid proteins;
- and
- one or more second RNA molecules, encoded by a nucleotide sequence comprising a targeting ta sequence reverse and complementary to a targeted site, a Cas13 protein recognition sequence, and the capsid protein binding tag recognizing and binding to the RNA-binding motif of one of the capsid proteins;
- wherein the capsid protein binding tag is encoded by a virus-like particle recognition sequence as denoted by SEQ ID NO:
- 1, and the RNA-binding motif comprises an amino acid sequence as denoted by SEQ ID NO:
- 15;
- and
- wherein the one or more first RNA molecules and the one or more second RNA molecules are encapsulated in the virus-like particle.
6 more elements
Dependencies are inferred from the claim text.